These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1465854)

  • 21. Effect of amino acid residue matching for HLA molecule in graft survival in renal transplantation.
    Ogahara S; Naito S; Noda R; Michinaga I; Murata T
    Transplant Proc; 1996 Jun; 28(3):1260-1. PubMed ID: 8658650
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
    Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract]   [Full Text] [Related]  

  • 25. ABO incompatible kidney transplantation with skin grafting.
    Haberal M; Gülay H; Arslan G; Bilgin N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):781-2. PubMed ID: 2650268
    [No Abstract]   [Full Text] [Related]  

  • 26. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
    Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
    Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal transplantation across the ABO barrier.
    Alkhunaizi AM
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):311-5. PubMed ID: 16970249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO incompatibility in liver transplantation: a single center experience.
    Steininger R; Mühlbacher F; Hamilton G; Zadrobilek E; Höcker P; Hajek A; Piza F
    Transplant Proc; 1987 Dec; 19(6):4586-8. PubMed ID: 3321624
    [No Abstract]   [Full Text] [Related]  

  • 29. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The graft survival curve: ideology and rhetoric.
    Guttmann RD
    Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of HLA and ABO antigens on graft rejection and survival.
    Sanfilippo F
    Clin Lab Med; 1991 Sep; 11(3):537-50. PubMed ID: 1934964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K; Kim YS; Kim SI
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal transplantation across the ABO barrier--a 9-year experience.
    Slapak M; Digard N; Ahmed M; Shell T; Thompson F
    Transplant Proc; 1990 Aug; 22(4):1425-8. PubMed ID: 2389348
    [No Abstract]   [Full Text] [Related]  

  • 34. Fully parametric analysis of kidney graft survival.
    Vereerstraeten P
    Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
    [No Abstract]   [Full Text] [Related]  

  • 35. Serial interleukin-6 blood levels early after cardiac transplantation.
    Weyand M; Krehmeier M; Fahrenkamp A; Middendorf C; Redmann M; Schwartz C; Konertz W; Scheld HH
    Transplant Proc; 1992 Dec; 24(6):2546. PubMed ID: 1334584
    [No Abstract]   [Full Text] [Related]  

  • 36. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney].
    Sierńko J
    Ann Acad Med Stetin; 2004; 50(1):53-67. PubMed ID: 16871744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal transplantation across a blood group barrier--'A2' kidneys to 'O' recipients.
    Brynger H; Rydberg L; Samuelsson B; Blohmé I; Lindholm A; Sandberg L
    Proc Eur Dial Transplant Assoc; 1983; 19():427-31. PubMed ID: 6348743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 40. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.